経口血糖降下薬(OAD)治療の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21APR4299)
◆英語タイトル:Global Oral Antidiabetic (OAD) Treatment Market Size, Status and Forecast 2021-2027
◆商品コード:QY21APR4299
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年4月
◆ページ数:92
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥526,500見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥789,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、経口血糖降下薬(OAD)治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(スルホニル尿素剤、ビグアニド、腸内α-グルコシダーゼ阻害剤、その他)、用途別市場規模(病院、診療所、糖尿病治療センター、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・経口血糖降下薬(OAD)治療の市場動向
・企業の競争状況、市場シェア
・経口血糖降下薬(OAD)治療の種類別市場規模(スルホニル尿素剤、ビグアニド、腸内α-グルコシダーゼ阻害剤、その他)
・経口血糖降下薬(OAD)治療の用途別市場規模(病院、診療所、糖尿病治療センター、その他)
・経口血糖降下薬(OAD)治療の北米市場規模2016-2027(アメリカ、カナダ)
・経口血糖降下薬(OAD)治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・経口血糖降下薬(OAD)治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・経口血糖降下薬(OAD)治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・経口血糖降下薬(OAD)治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Pfizer、Eli Lilly、Merck、Sanofi、AstraZeneca、Glenmark、Novartis、Boehringer Ingelheim、Novo Nordisk、Mannkind)
・結論
【レポートの概要】

Diabetic is the condition where the sugar (glucose) level is high in the blood or the production of the insulin is inadequate. Diabetes main type the very first one is Type 1 and the second is Type 2, both the diabetic are most commonly find in the current scenario, apart from this many other diabetics case are also been listed as gestational diabetes and others. Various treatment method are present in the market injection, oral and others. The mostly used method of treatment or managing the diabetes is the oral.
North America has the 44.3 million population with diabetes in 2015 according to the IDF, same as Europe have 59.8 million in 2015 according to IDF and Asia Pacific has 60% diabetic population as compared with world according to Asian Diabetes Prevention Initiative.

Market Analysis and Insights: Global Oral Antidiabetic (OAD) Treatment Market
The global Oral Antidiabetic (OAD) Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Oral Antidiabetic (OAD) Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Oral Antidiabetic (OAD) Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Oral Antidiabetic (OAD) Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Oral Antidiabetic (OAD) Treatment market.

Global Oral Antidiabetic (OAD) Treatment Scope and Market Size
Oral Antidiabetic (OAD) Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Oral Antidiabetic (OAD) Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Sulphonylureas
Biguanides
Intestinal α-Glucosidase Inhibitors
Others

Segment by Application
Hospital
Clinics
Diabetics Treatment Centres
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Eli Lilly
Merck
Sanofi
AstraZeneca
Glenmark
Novartis
Boehringer Ingelheim
Novo Nordisk

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oral Antidiabetic (OAD) Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Sulphonylureas
1.2.3 Biguanides
1.2.4 Intestinal α-Glucosidase Inhibitors
1.2.5 Others
1.3 Market by Application
1.3.1 Global Oral Antidiabetic (OAD) Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Diabetics Treatment Centres
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Oral Antidiabetic (OAD) Treatment Market Perspective (2016-2027)
2.2 Oral Antidiabetic (OAD) Treatment Growth Trends by Regions
2.2.1 Oral Antidiabetic (OAD) Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Oral Antidiabetic (OAD) Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Oral Antidiabetic (OAD) Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Oral Antidiabetic (OAD) Treatment Industry Dynamic
2.3.1 Oral Antidiabetic (OAD) Treatment Market Trends
2.3.2 Oral Antidiabetic (OAD) Treatment Market Drivers
2.3.3 Oral Antidiabetic (OAD) Treatment Market Challenges
2.3.4 Oral Antidiabetic (OAD) Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Oral Antidiabetic (OAD) Treatment Players by Revenue
3.1.1 Global Top Oral Antidiabetic (OAD) Treatment Players by Revenue (2016-2021)
3.1.2 Global Oral Antidiabetic (OAD) Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Oral Antidiabetic (OAD) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Oral Antidiabetic (OAD) Treatment Revenue
3.4 Global Oral Antidiabetic (OAD) Treatment Market Concentration Ratio
3.4.1 Global Oral Antidiabetic (OAD) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oral Antidiabetic (OAD) Treatment Revenue in 2020
3.5 Oral Antidiabetic (OAD) Treatment Key Players Head office and Area Served
3.6 Key Players Oral Antidiabetic (OAD) Treatment Product Solution and Service
3.7 Date of Enter into Oral Antidiabetic (OAD) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Oral Antidiabetic (OAD) Treatment Breakdown Data by Type
4.1 Global Oral Antidiabetic (OAD) Treatment Historic Market Size by Type (2016-2021)
4.2 Global Oral Antidiabetic (OAD) Treatment Forecasted Market Size by Type (2022-2027)

5 Oral Antidiabetic (OAD) Treatment Breakdown Data by Application
5.1 Global Oral Antidiabetic (OAD) Treatment Historic Market Size by Application (2016-2021)
5.2 Global Oral Antidiabetic (OAD) Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Oral Antidiabetic (OAD) Treatment Market Size (2016-2027)
6.2 North America Oral Antidiabetic (OAD) Treatment Market Size by Type
6.2.1 North America Oral Antidiabetic (OAD) Treatment Market Size by Type (2016-2021)
6.2.2 North America Oral Antidiabetic (OAD) Treatment Market Size by Type (2022-2027)
6.2.3 North America Oral Antidiabetic (OAD) Treatment Market Size by Type (2016-2027)
6.3 North America Oral Antidiabetic (OAD) Treatment Market Size by Application
6.3.1 North America Oral Antidiabetic (OAD) Treatment Market Size by Application (2016-2021)
6.3.2 North America Oral Antidiabetic (OAD) Treatment Market Size by Application (2022-2027)
6.3.3 North America Oral Antidiabetic (OAD) Treatment Market Size by Application (2016-2027)
6.4 North America Oral Antidiabetic (OAD) Treatment Market Size by Country
6.4.1 North America Oral Antidiabetic (OAD) Treatment Market Size by Country (2016-2021)
6.4.2 North America Oral Antidiabetic (OAD) Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Oral Antidiabetic (OAD) Treatment Market Size (2016-2027)
7.2 Europe Oral Antidiabetic (OAD) Treatment Market Size by Type
7.2.1 Europe Oral Antidiabetic (OAD) Treatment Market Size by Type (2016-2021)
7.2.2 Europe Oral Antidiabetic (OAD) Treatment Market Size by Type (2022-2027)
7.2.3 Europe Oral Antidiabetic (OAD) Treatment Market Size by Type (2016-2027)
7.3 Europe Oral Antidiabetic (OAD) Treatment Market Size by Application
7.3.1 Europe Oral Antidiabetic (OAD) Treatment Market Size by Application (2016-2021)
7.3.2 Europe Oral Antidiabetic (OAD) Treatment Market Size by Application (2022-2027)
7.3.3 Europe Oral Antidiabetic (OAD) Treatment Market Size by Application (2016-2027)
7.4 Europe Oral Antidiabetic (OAD) Treatment Market Size by Country
7.4.1 Europe Oral Antidiabetic (OAD) Treatment Market Size by Country (2016-2021)
7.4.2 Europe Oral Antidiabetic (OAD) Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Size (2016-2027)
8.2 Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Size by Type
8.2.1 Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Size by Application
8.3.1 Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Size by Region
8.4.1 Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Oral Antidiabetic (OAD) Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Oral Antidiabetic (OAD) Treatment Market Size (2016-2027)
9.2 Latin America Oral Antidiabetic (OAD) Treatment Market Size by Type
9.2.1 Latin America Oral Antidiabetic (OAD) Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Oral Antidiabetic (OAD) Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Oral Antidiabetic (OAD) Treatment Market Size by Type (2016-2027)
9.3 Latin America Oral Antidiabetic (OAD) Treatment Market Size by Application
9.3.1 Latin America Oral Antidiabetic (OAD) Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Oral Antidiabetic (OAD) Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Oral Antidiabetic (OAD) Treatment Market Size by Application (2016-2027)
9.4 Latin America Oral Antidiabetic (OAD) Treatment Market Size by Country
9.4.1 Latin America Oral Antidiabetic (OAD) Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Oral Antidiabetic (OAD) Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size (2016-2027)
10.2 Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size by Type
10.2.1 Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size by Application
10.3.1 Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size by Country
10.4.1 Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Oral Antidiabetic (OAD) Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Oral Antidiabetic (OAD) Treatment Introduction
11.1.4 Pfizer Revenue in Oral Antidiabetic (OAD) Treatment Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Eli Lilly
11.2.1 Eli Lilly Company Details
11.2.2 Eli Lilly Business Overview
11.2.3 Eli Lilly Oral Antidiabetic (OAD) Treatment Introduction
11.2.4 Eli Lilly Revenue in Oral Antidiabetic (OAD) Treatment Business (2016-2021)
11.2.5 Eli Lilly Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Oral Antidiabetic (OAD) Treatment Introduction
11.3.4 Merck Revenue in Oral Antidiabetic (OAD) Treatment Business (2016-2021)
11.3.5 Merck Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Oral Antidiabetic (OAD) Treatment Introduction
11.4.4 Sanofi Revenue in Oral Antidiabetic (OAD) Treatment Business (2016-2021)
11.4.5 Sanofi Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Company Details
11.5.2 AstraZeneca Business Overview
11.5.3 AstraZeneca Oral Antidiabetic (OAD) Treatment Introduction
11.5.4 AstraZeneca Revenue in Oral Antidiabetic (OAD) Treatment Business (2016-2021)
11.5.5 AstraZeneca Recent Development
11.6 Glenmark
11.6.1 Glenmark Company Details
11.6.2 Glenmark Business Overview
11.6.3 Glenmark Oral Antidiabetic (OAD) Treatment Introduction
11.6.4 Glenmark Revenue in Oral Antidiabetic (OAD) Treatment Business (2016-2021)
11.6.5 Glenmark Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Oral Antidiabetic (OAD) Treatment Introduction
11.7.4 Novartis Revenue in Oral Antidiabetic (OAD) Treatment Business (2016-2021)
11.7.5 Novartis Recent Development
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Company Details
11.8.2 Boehringer Ingelheim Business Overview
11.8.3 Boehringer Ingelheim Oral Antidiabetic (OAD) Treatment Introduction
11.8.4 Boehringer Ingelheim Revenue in Oral Antidiabetic (OAD) Treatment Business (2016-2021)
11.8.5 Boehringer Ingelheim Recent Development
11.9 Novo Nordisk
11.9.1 Novo Nordisk Company Details
11.9.2 Novo Nordisk Business Overview
11.9.3 Novo Nordisk Oral Antidiabetic (OAD) Treatment Introduction
11.9.4 Novo Nordisk Revenue in Oral Antidiabetic (OAD) Treatment Business (2016-2021)
11.9.5 Novo Nordisk Recent Development
11.10 Mannkind
11.10.1 Mannkind Company Details
11.10.2 Mannkind Business Overview
11.10.3 Mannkind Oral Antidiabetic (OAD) Treatment Introduction
11.10.4 Mannkind Revenue in Oral Antidiabetic (OAD) Treatment Business (2016-2021)
11.10.5 Mannkind Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details



【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 経口血糖降下薬(OAD)治療の世界市場規模・現状・予測2021年-2027年(Global Oral Antidiabetic (OAD) Treatment Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。